In a world first, the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved trofolastat to detect cancerous lesions in men with prostate cancer.
A recent advisory panel to the Food and Drug Administration (FDA) has cast significant doubt on the potential approval of MDMA-assisted therapy for post-traumatic stress disorder (PTSD).
In June, Alzheimer's and brain awareness month, Mayo Clinic researchers have identified unique molecular signatures of blood-brain barrier dysfunction in Alzheimer's disease.
Imagine a world where children's medicine tastes like chocolate, seniors can take just one pill for all their daily medications, and you can get a drug made specifically for your unique health needs right at your local pharmacy.
Scientists have developed new types of fibers that could revolutionize medical treatments. Made from a biodegradable polymer PLA (plastic) and reinforced with special nanoparticles, these fibers show great promise for use in medical implants, improved healing, reduced infection risk, and a wider range of medical applications.
In a study, researchers from the University of Basel and the University Hospital Basel have uncovered a promising new approach to combat the Epstein-Barr virus (EBV), a common virus that affects 90% of the adult population.
The University of Michigan Health Rogel Cancer Center has revealed that changing the dosing schedule for common cancer therapy could greatly reduce greenhouse gas emissions without compromising the patient's outcomes.
Researchers suggest that microwave ablation, a minimally invasive procedure, could offer comparable progression-free survival rates to surgery with fewer complications.
A minimally invasive treatment for prostate cancer, using a combination of MRI and transurethral ultrasound, has shown effectiveness in a recent study.
Dealing with skin conditions can be challenging, especially when two rare diseases, generalised pustular psoriasis (GPP) and acute generalised exanthematous pustulosis (AGEP), have similar symptoms, making it challenging to differentiate between them.
Researchers in Portugal look at the critical gaps in knowledge against type 2 diabetes (T2D) patients, potentially impacting their long-term health outcomes.
